Last edition
News about "BIOVECTRA"
Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
BIOVECTRA | 12/03/2026 | By News Bureau
Agilent Announces Acquisition of BIOVECTRA
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.
BIOVECTRA | 24/09/2024 | By Aishwarya | 563
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy